Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Our moderators are patients and caregivers who intimately understand the struggles associated with Renal Medullary Carcinoma / RMC. We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you!
